Sixteen patients (40%) showed persisting thrombocytopenia, fourteen of these in a range from 100–150 × 103/μL, one patient required thrombocyte transfusions until last follow-up and one was diagnosed with immune thrombocytopenia and received TPO-agonists. The gene discussed is TPO; the disease is autoimmune thrombocytopenic purpura.